Company intelligence / Profile preview

Marrow Access Technologies

Minnetonka, Minnesota, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

The SmartShot device is commercially available in the US for marrow stimulation therapy, providing 2X greater access to stem cell-rich marrow with 66% less bone disruption than traditional microfracture; used in over 1,000 patients with positive surgeon feedback.[1][4]

Therapeutic areas: Rheumatology
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Marrow Access Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Marrow Access Technologies.

Explore the full profile